$SNWV
SANUWAVE Health, Inc.

2023 Q4 Form 10-Q Financial Statement

#000114036123052479 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $6.994M $4.953M
YoY Change 27.16% 18.89%
Cost Of Revenue $2.159M $1.412M
YoY Change 24.01% 133.0%
Gross Profit $4.835M $3.541M
YoY Change 28.62% -0.53%
Gross Profit Margin 69.13% 71.49%
Selling, General & Admin $3.464M $3.720M
YoY Change -46.8% -26.39%
% of Gross Profit 71.64% 105.06%
Research & Development $143.0K $165.0K
YoY Change 95.89% 5.1%
% of Gross Profit 2.96% 4.66%
Depreciation & Amortization $248.0K $265.0K
YoY Change 29.84% -54.86%
% of Gross Profit 5.13% 7.48%
Operating Expenses $3.796M $4.072M
YoY Change -43.97% -24.59%
Operating Profit $1.039M -$531.0K
YoY Change -134.45% -71.14%
Interest Expense $17.20M -$23.17M
YoY Change -497.39% -1631.33%
% of Operating Profit 1655.73%
Other Income/Expense, Net -$3.000K -$23.17M
YoY Change -1723.62%
Pretax Income $18.24M -$23.70M
YoY Change -323.63% 5638.5%
Income Tax $4.000K $0.00
% Of Pretax Income 0.02%
Net Earnings $18.24M -$23.70M
YoY Change -323.52% 5638.5%
Net Earnings / Revenue 260.72% -478.5%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share $0.02 -$0.03
COMMON SHARES
Basic Shares Outstanding 1.026B 1.026B
Diluted Shares Outstanding 893.0M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.797M $1.095M
YoY Change 55.85% -1.53%
Cash & Equivalents $1.797M $1.095M
Short-Term Investments
Other Short-Term Assets $1.722M $1.355M
YoY Change 202.11% -29.97%
Inventory $2.951M $1.713M
Prepaid Expenses
Receivables $3.314M $3.231M
Other Receivables $0.00 $0.00
Total Short-Term Assets $9.784M $7.394M
YoY Change 47.79% 7.74%
LONG-TERM ASSETS
Property, Plant & Equipment $938.0K $1.079M
YoY Change 25.07% 60.33%
Goodwill $7.260M $7.260M
YoY Change 0.0% 0.0%
Intangibles $4.434M $4.609M
YoY Change -13.69%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $12.63M $12.95M
YoY Change -4.69% -2.25%
TOTAL ASSETS
Total Short-Term Assets $9.784M $7.394M
Total Long-Term Assets $12.63M $12.95M
Total Assets $22.42M $20.34M
YoY Change 12.8% 1.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.705M $4.623M
YoY Change 29.66% -8.55%
Accrued Expenses $5.999M $6.359M
YoY Change -29.52% 55.1%
Deferred Revenue $92.00K $68.00K
YoY Change 53.33% -72.69%
Short-Term Debt $22.85M $27.32M
YoY Change 58.53% -14.64%
Long-Term Debt Due $7.109M $10.05M
YoY Change -70.53% -30.93%
Total Short-Term Liabilities $64.76M $85.43M
YoY Change 7.59% 62.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $839.0K $834.0K
YoY Change 25.6% 78.21%
Total Long-Term Liabilities $839.0K $862.0K
YoY Change 20.55% 73.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.76M $85.43M
Total Long-Term Liabilities $839.0K $862.0K
Total Liabilities $65.59M $86.30M
YoY Change 7.74% 62.94%
SHAREHOLDERS EQUITY
Retained Earnings -$220.0M -$238.3M
YoY Change 13.29% 28.05%
Common Stock $1.140M $1.026M
YoY Change 107.65% 86.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$43.18M -$65.95M
YoY Change
Total Liabilities & Shareholders Equity $22.42M $20.34M
YoY Change 12.8% 1.16%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $18.24M -$23.70M
YoY Change -323.52% 5638.5%
Depreciation, Depletion And Amortization $248.0K $265.0K
YoY Change 29.84% -54.86%
Cash From Operating Activities -$1.285M -$2.038M
YoY Change -67.82% -74.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $8.000K $13.00K
YoY Change -101.16% -82.43%
Cash From Investing Activities $177.0K $13.00K
YoY Change -125.65% -82.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.855M 1.930M
YoY Change -60.7% -74.47%
NET CHANGE
Cash From Operating Activities -1.285M -2.038M
Cash From Investing Activities 177.0K 13.00K
Cash From Financing Activities 1.855M 1.930M
Net Change In Cash 747.0K -95.00K
YoY Change 1918.92% -72.14%
FREE CASH FLOW
Cash From Operating Activities -$1.285M -$2.038M
Capital Expenditures $0.00
Free Cash Flow -$2.038M
YoY Change -74.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
548737651
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
548737651
CY2023Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-23700000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-23700000
CY2023Q3 us-gaap Gross Profit
GrossProfit
3541000
CY2023Q3 snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-44042000
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-4596000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1139000
us-gaap Net Income Loss
NetIncomeLoss
-44042000
us-gaap Net Income Loss
NetIncomeLoss
-4596000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23693000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1139000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44048000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4590000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1412000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1157000
us-gaap Cost Of Revenue
CostOfRevenue
3876000
us-gaap Cost Of Revenue
CostOfRevenue
3141000
CY2022Q3 us-gaap Gross Profit
GrossProfit
3009000
us-gaap Gross Profit
GrossProfit
9528000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
494000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
187000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
189000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
563000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
575000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4072000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5494000
us-gaap Operating Expenses
OperatingExpenses
11107000
us-gaap Operating Expenses
OperatingExpenses
15590000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-531000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2485000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1579000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7489000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1026078464
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1037000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1176000
dei Entity Address Address Line1
EntityAddressAddressLine1
11495 Valley View Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55344
CY2023Q3 us-gaap Revenues
Revenues
4953000
CY2022Q3 us-gaap Revenues
Revenues
4166000
us-gaap Revenues
Revenues
13404000
us-gaap Revenues
Revenues
11242000
us-gaap Gross Profit
GrossProfit
8101000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2681000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3498000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9484000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1650000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3430000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5037000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
157000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
436000
CY2023Q3 snwv Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
19325000
CY2022Q3 snwv Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-5252000
snwv Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
29943000
snwv Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-16597000
CY2022Q3 snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
0
snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
0
snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
3434000
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-86000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-297000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-42463000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2893000
CY2022Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1139000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000
snwv Class Of Warrant Or Right Weighted Average Exercise Price Of Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceOfExercised
0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
892956000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
561070000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
683771000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
542485000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1350464000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1489633000
CY2023Q3 snwv Accrued Registration Penalties Current
AccruedRegistrationPenaltiesCurrent
1583000
CY2022Q4 snwv Accrued Registration Penalties Current
AccruedRegistrationPenaltiesCurrent
1583000
CY2023Q3 snwv Accrued License Fees Current
AccruedLicenseFeesCurrent
892000
CY2022Q4 snwv Accrued License Fees Current
AccruedLicenseFeesCurrent
892000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1177000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
586000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2665000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4585000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
866000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6359000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8512000
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001417663
dei Document Type
DocumentType
10-Q
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52985
dei Entity Registrant Name
EntityRegistrantName
SANUWAVE Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
419-7525
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6678000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1039000
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
16000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23169000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1346000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
892956020
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
892956020
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
561069625
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
561069625
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
683771214
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
683771214
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
542484779
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
542484779
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-60838000
CY2023Q3 snwv Shares Issued For Settlement Of Debt And Warrants
SharesIssuedForSettlementOfDebtAndWarrants
18577000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-23700000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
7000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-65954000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-35535000
CY2022Q3 snwv Shares Issued For Settlement Of Debt And Warrants
SharesIssuedForSettlementOfDebtAndWarrants
1361000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-1139000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-35313000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-41010000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
527000
snwv Shares Issued For Settlement Of Debt And Warrants
SharesIssuedForSettlementOfDebtAndWarrants
18577000
us-gaap Profit Loss
ProfitLoss
-44042000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-65954000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-38958000
snwv Stock Issued During Period Value Cashless Warrant Exercises
StockIssuedDuringPeriodValueCashlessWarrantExercises
2166000
snwv Stock Issued During Period Warrants Exercised Value
StockIssuedDuringPeriodWarrantsExercisedValue
100000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3720000
snwv Shares Issued For Settlement Of Debt And Warrants
SharesIssuedForSettlementOfDebtAndWarrants
1361000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
888000
us-gaap Profit Loss
ProfitLoss
-4596000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-35313000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
224000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
888000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-297000
snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
0
snwv Loss On Issuance Of Debt
LossOnIssuanceOfDebt
3434000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-51000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
13000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1022000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2940000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1202000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
12366000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2994000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
640000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
100000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2981000
snwv Warrants Issued In Conjunction With Senior Secured And Convertible Promissory Note Payable
WarrantsIssuedInConjunctionWithSeniorSecuredAndConvertiblePromissoryNotePayable
570000
snwv Warrants Issued In Conjunction With Senior Secured And Convertible Promissory Note Payable
WarrantsIssuedInConjunctionWithSeniorSecuredAndConvertiblePromissoryNotePayable
4117000
snwv Embedded Conversion Option With Issuances Of Convertible Debt And Bridge Notes Payable
EmbeddedConversionOptionWithIssuancesOfConvertibleDebtAndBridgeNotesPayable
-520000
snwv Embedded Conversion Option With Issuances Of Convertible Debt And Bridge Notes Payable
EmbeddedConversionOptionWithIssuancesOfConvertibleDebtAndBridgeNotesPayable
2309000
snwv Reclassification Of Warrant Liability Due To Cashless Warrant Exercise
ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise
0
snwv Reclassification Of Warrant Liability Due To Cashless Warrant Exercise
ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise
2166000
snwv Working Capital Balances Refinanced Into Convertible Notes Payable
WorkingCapitalBalancesRefinancedIntoConvertibleNotesPayable
0
snwv Working Capital Balances Refinanced Into Convertible Notes Payable
WorkingCapitalBalancesRefinancedIntoConvertibleNotesPayable
2273000
snwv Settlement Of Debt And Warrants With Stock
SettlementOfDebtAndWarrantsWithStock
0
snwv Settlement Of Debt And Warrants With Stock
SettlementOfDebtAndWarrantsWithStock
1361000
snwv Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable
CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable
0
snwv Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable
CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable
3720000
CY2023Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
732000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q3 snwv Exchange Ratio
ExchangeRatio
0.0033
CY2023Q3 snwv Probability Of Closing Merger
ProbabilityOfClosingMerger
0.85
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4821000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3919000
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
132000
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
247000
CY2023Q3 us-gaap Revenues
Revenues
4953000
CY2022Q3 us-gaap Revenues
Revenues
4166000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12727000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10307000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
677000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
935000
us-gaap Revenues
Revenues
13404000
us-gaap Revenues
Revenues
11242000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
snwv-20230930_cal.xml Edgar Link unprocessable
0001140361-23-052479-index-headers.html Edgar Link pending
0001140361-23-052479-index.html Edgar Link pending
0001140361-23-052479.txt Edgar Link pending
0001140361-23-052479-xbrl.zip Edgar Link pending
ef20012495_10q.htm Edgar Link pending
ef20012495_ex31-1.htm Edgar Link pending
ef20012495_ex31-2.htm Edgar Link pending
ef20012495_ex32-1.htm Edgar Link pending
ef20012495_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
ef20012495_10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snwv-20230930.xsd Edgar Link pending
snwv-20230930_def.xml Edgar Link unprocessable
snwv-20230930_lab.xml Edgar Link unprocessable
snwv-20230930_pre.xml Edgar Link unprocessable